- A Case of Hereditary Spherocytosis Coexisting with Gilbert's Syndrome
-
Lee MJ, Chang YH, Kang SH, Mun SK, Kim H, Han CJ, Kim J, Kang HJ
- KMID: 1501640
- Korean J Gastroenterol.
- 2013 Mar;61(3):166-169.
- doi: 10.4166/kjg.2013.61.3.166
We recently encountered a case of hereditary spherocytosis coexisting with Gilbert's syndrome. Patient was initially diagnosed with Gilbert's syndrome and observed, but other findings suggestive of concurrent hemolysis, such as... -
- CITED
-
- Close
- SHARE
-
- Close
- Acute Hemolysis and Renal Failure caused by Hepatitis A Infection with Underlying Glucose-6-Phosphate Dehydrogenase Deficiency
-
Jekarl DW, Oh EJ, Park YJ, Han KJ, Lee SW, Park CW
- KMID: 1781482
- Korean J Lab Med.
- 2007 Jun;27(3):188-191.
- doi: 10.3343/kjlm.2007.27.3.188
Although glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme disorder worldwide, it has rarely been reported among Korean. The patient was previously healthy 39 yr old male who showed... -
- CITED
-
- Close
- SHARE
-
- Close
- Central Pontine Myelinolysis in a Patient with Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation: A Case Report
-
Lim KH, Kim S, Lee YS, Kim KH, Kim J, Rhee JY, Kim HJ, Yi HG, Oh SY, Lim JH, Han SW, Lee S, Kim I, Yoon SS, Park S, Kim BK
- KMID: 1713469
- J Korean Med Sci.
- 2008 Apr;23(2):324-327.
- doi: 10.3346/jkms.2008.23.2.324
We describe a 37-yr-old man who developed central pontine myelinolysis (CPM) after allogeneic hematopoietic stem cell transplantation (HSCT) for acute lymphoblastic leukemia. After HSCT, desquamation developed on the whole body... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
-
Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK
- KMID: 2413116
- Clin Mol Hepatol.
- 2017 Jun;23(2):128-137.
- doi: 10.3350/cmh.2016.0071
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS)... -
- CITED
-
- Close
- SHARE
-
- Close
